Xilio Therapeutics, Inc. (XLO)

Xilio Therapeutics Revenue

Xilio Therapeutics had revenue of $18.69M in the quarter ending June 30, 2026, with 131.22% growth. This brings the company's revenue in the last twelve months to $64.09M, up 327.25% year-over-year. In the year 2025, Xilio Therapeutics had annual revenue of $43.77M with 589.88% growth.

• Revenue (ttm): $64.09M
• Revenue Growth: +327.25%
• P/S Ratio: 0.92
• Revenue / Employee: $843,316
• Employees: 76
• Market Cap: 58.96M

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	43.77M	37.42M	589.88%
Dec 31, 2024	6.34M	-	-
Dec 31, 2023	-	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	-	-	-

Data Source: S&P Global Market Intelligence Last updated: Aug 12, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 7, 2026

Data Sources Report a data error